Previous 10 | Next 10 |
Gainers: Protagonist Therapeutics (PTGX) +10%. Marriott International (MAR) +7%. Aurora Innovation (AUR) +6%. MannKind Corporation (MNKD) +5%. Arcimoto (FUV) +5%. Losers: Enanta Pharmaceuticals (ENTA) -15%. Cisco Systems (CSCO) -12%. Limelight Networks (LLNW) -5%. Copart (CPRT) -4%....
When it comes to unusual options activity, Reddit, Twitter, and even stock market chat rooms seem to love this data. There are unusual options activity scanners that you can use to find stocks with irregular volume in their options chains. There are also websites like ours that scour throug...
MannKind (NASDAQ:MNKD) is acquiring Zealand Pharma's (ZEAL) V-Go wearable insulin delivery device for $10M, plus sales-based milestones and the cost of certain inventory. MannKind intends to strengthen its commitment to provide mealtime diabetes solutions through this transaction, m...
The once-daily insulin delivery device strengthens MannKind’s commitment to offering innovative mealtime diabetes solutions DANBURY, Conn. and WESTLAKE VILLAGE, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused o...
Image source: The Motley Fool. MannKind Corporation (NASDAQ: MNKD) Q1 2022 Earnings Call May 05, 2022 , 5:00 p.m. ET Operator Continue reading For further details see: MannKind Corporation (MNKD) Q1 2022 Earnings Call Transcript
MannKind Corporation (MNKD) Q1 2022 Earnings Conference Call May 5, 2022 5:00 PM ET Company Participants Michael Castagna – Chief Executive Officer Steven Binder – Chief Financial Officer Conference Call Participants Brandon Folkes – Cantor Fitzgerald Gregory Renza ȁ...
MannKind press release (NASDAQ:MNKD): Q1 GAAP EPS of -$0.10 in-line. Revenue of $11.99M (-31.3% Y/Y) beats by $1.38M. 1Q 2022 Afrezza Net Revenue of $9.8 million; +21% vs. 1Q 2021 1Q 2022 Afrezza Gross Margin 77%; Gross Profit +99% vs 1Q 2021 $233.0 million of Cash, Cash Equivalents, and Inve...
1Q 2022 Afrezza Net Revenue of $9.8 million; +21% vs. 1Q 2021 1Q 2022 Afrezza Gross Margin 77%; Gross Profit +99% vs 1Q 2021 $233.0 million of Cash, Cash Equivalents, and Investments at March 31, 2022 Tyvaso DPI PDUFA date May 2022 DANBURY, Conn. and WEST...
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) will release its 2022 first quarter financial results and its management will host a conference call to discuss the financial results and corporate updates at 5:00 PM (Eas...
Simplified 2x dose of Technosphere ® Insulin (TI) produced a statistically significant improvement in PPGE between Dose 1 & 2 from 45-120 minutes Higher dose of TI resulted in a mean difference of 52 mg/dL in PPGE at 120 minutes, with no new safety concerns ...
News, Short Squeeze, Breakout and More Instantly...
2024-05-09 00:15:12 ET Image source: The Motley Fool. MannKind (NASDAQ: MNKD) Q1 2024 Earnings Call May 08, 2024 , 5:00 p.m. ET Operator Continue reading For further details see: MannKind (MNKD) Q1 2024 Earnings Call Transcript
1Q 2024 Total revenues of $66M; +63% vs. 1Q 2023 1Q 2024 Net income of $11M; Non-GAAP net income of $15M $304M of cash and cash equivalents and investments at March 31, 2024 In early April, repaid Midcap senior-secured debt and Mann Group convertible debt totaling a...
Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...